Perampanel as precision therapy in rare genetic epilepsies
Andreea Nissenkorn(University Hospital of Lausanne), Angelo Russo(Istituto delle Scienze Neurologiche di Bologna), B. Stark(Johannes Kepler University of Linz), Marya Bobylova(Epilepsy Foundation), Maria Panagiotou(University Hospital of Larissa), Susanne Schubert‐Bast(Goethe University Frankfurt), Μαρία Τσεκούρα(University Children's Hospital Zurich), Berten Ceulemans(University of Antwerp), Celina von Stülpnagel(Dr. Brill + Dr. Steinmann (Germany)), Anne Fuchs(Suizhou Central Hospital), Emanuele Cerulli Irelli(Sapienza University of Rome), С.Л. Куликова(Republican Scientific and Practical Center of Neurology and Neurosurgery), Georgia Ramantani(University Children's Hospital Zurich), О. А. Пылаева(Epilepsy Foundation), Alessandro Orsini(University of Pisa), Gerhard Kluger(Paracelsus Medical University), Allan Bayat(University of Southern Denmark), Martha Feucht(Medical University of Vienna), Gali Heimer(Edmond and Lily Safra Children's Hospital), Matthias De Wachter(University of Antwerp), Brigitte Herdt(Institut für Palliative Care), Antonietta Coppola(University of Naples Federico II), К. Yu. Мukhin(Epilepsy Foundation), Paolo Bonanni(IRCCS Eugenio Medea), Andreas van Baalen(Lausitzer Seenland Klinikum), Claudia Cuccurullo(Ospedale Antonio Cardarelli), Carlo Di Bonaventura(Sapienza University of Rome), Pasquale Striano(Great Ormond Street Hospital), Stefania Nicassio(Istituto delle Scienze Neurologiche di Bologna), Burkhard Puest(Katholisches Kinderkrankenhaus Wilhelmstift), Paolo Ricciardelli(Azienda Unità Sanitaria Locale Della Romagna), Milka Pringsheim(Schön Klinik Vogtareuth), Gudrun Gröppel(Johannes Kepler University of Linz)
Cited by 43
Related Papers
Recurrent Rearrangements of Chromosome 1q21.1 and Variable Pediatric Phenotypes
|New England Journal of Medicine|2008|811
Fenfluramine hydrochloride for the treatment of seizures in Dravet syndrome: a randomised, double-blind, placebo-controlled trial
|The Lancet|2019|361
The Pharmacoresistant Epilepsy: An Overview on Existent and New Emerging Therapies
|Frontiers in Neurology|2021|260
AMPA receptor GluA2 subunit defects are a cause of neurodevelopmental disorders
|Nature Communications|2019|249
Microbiota-gut brain axis involvement in neuropsychiatric disorders
|Expert Review of Neurotherapeutics|2019|177